Familial expression of anti-Saccharomyces cerevisiae mannan antibodies in affected and unaffected relatives of patients with Crohn's disease
Open Access
- 1 January 2000
- Vol. 46 (1) , 58-63
- https://doi.org/10.1136/gut.46.1.58
Abstract
BACKGROUND Crohn's disease is a familial disorder, and antiglycan antibodies to the cell wall mannan ofSaccharomyces cerevisiae (ASCA) are highly correlated with Crohn's disease. AIMS To determine whether there is a familial pattern for expression of serum levels of anti-mannan Ig, and whether this trait is expressed in clinically unaffected Crohn's disease family members. METHODS 349 patients with Crohn's disease, 87 Crohn's disease affected relatives, 333 inflammatory bowel disease (IBD) free relatives, 58 spouses, and 190 healthy control patients were studied. Serum IgG and IgA binding activity toS cerevisiae cell wall mannan was quantitated by ELISA. RESULTS A high percentage of patients with Crohn's disease (51.9%) and affected family members (56.3%) were seropositive for anti-mannan Ig, compared with the normal control population (3.7%). Seropositive and seronegative phenotypes of Crohn's disease probands were correlated among all affected relatives, and this association was stronger in affected first degree relatives. Statistical intraclass correlations of quantitative anti-mannan Ig levels revealed significantly less variation within, rather than between families. A significant familial aggregation was observed for affected relatives; this was even stronger for unaffected relatives. While a significant familial aggregation was observed among unaffected siblings pairs, there was no significant correlation among marital pairs. CONCLUSION Results show that anti-mannan Ig in family members affected and unaffected with Crohn's disease is a familial trait for both affected and unaffected relatives. The lack of concordance in marital pairs indicates that familiality is due in part to a genetic factor or childhood environmental exposure.Keywords
This publication has 47 references indexed in Scilit:
- Interleukin 10 suppresses experimental chronic, granulomatous inflammation induced by bacterial cell wall polymers.Gut, 1996
- Susceptibility locus for inflammatory bowel disease on chromosome 16 has a role in Crohn's disease, but not in ulcerative colitisHuman Molecular Genetics, 1996
- Two stage genome–wide search in inflammatory bowel disease provides evidence for susceptibility loci on chromosomes 3, 7 and 12Nature Genetics, 1996
- Controlled trial of metronidazole treatment for prevention of crohn's recurrence after ileal resectionGastroenterology, 1995
- Ulcerative colitis: a genetically heterogeneous disorder defined by genetic (HLA class II) and subclinical (antineutrophil cytoplasmic antibodies) markers.Journal of Clinical Investigation, 1993
- Familial empirical risks for inflammatory bowel disease: differences between Jews and non-Jews.Gut, 1993
- Antibodies to Mycobacterium paratuberculosis-specific protein antigens in Crohn's diseaseClinical and Experimental Immunology, 1992
- Reactivity of infiltrating T lymphocytes with microbial antigens in Crohn's diseaseThe Lancet, 1991
- Occupational distribution of inflammatory bowel disease among German employees.Gut, 1990
- Antibody to selected strains of Saccharomyces cerevisiae (baker's and brewer's yeast) and Candida albicans in Crohn's disease.Gut, 1990